The lack of trusted and secure platforms and privacy-aware analytics methods for secure sharing of personal data and proprietary/commercial/industrial data hampers the creation of a data market and data economy by limiting data sharing mostly to open data. This trend will continue if different technical standards, quality levels, and legal aspects are allowed to diverge uncontrollably. TRUSTS will ensure trust in the concept of data markets as a whole via its focus on developing a platform based on the experience of two large national projects, while allowing the integration and adoption of future platforms. The TRUSTS platform will act independently and as a platform federator, while investigating the legal and ethical aspects that apply on the entire data valorification chain, from data providers to consumers, i.e. it will (a) Set up a fully operational and GDPR-compliant European Data Marketplace for personal related data and non-personal related data targeting both personal and industrial use by leveraging existing data marketplaces (International Data Space and Data Market Austria) and enriching them with new functionalities and services. (b) Demonstrate and realise the potential of the TRUSTS Platform in 3 use cases targeting the industry sectors of corporate business data, specifically in the financial and telecom operator industries while ensuring it is supported by a viable, compliant and impactful governance, legal and business model. To create a European Data Market based on secure and trustworthy data exchanges, the TRUSTS consortium brings together technology providers that are already deeply involved in major national data market projects. This integration will be tested in practice by 6 companies, including 2 data providers, addressing 3 different use-cases. The TRUSTS technology and use-cases will be accompanied by business and legal and ethical considerations, which will ensure that the results of the project are sustainable beyond its duration

In line with industry needs, Moore’s law, scaling in ITRS 2013/2015, and ECSEL JU MASP 2016, the main objective of the TAKEMI5 project is to discover, develop and demonstrate lithographic, metrology, process and integration technologies enabling module integration for the 5 nm node. This is planned with available EUV/NA0.33 scanners that are optimized for mix and match with existing DUV/NA1.35 scanners, and with system design and development of a new hyper NA EUV lithography tool to enable more single exposure patterning at 5 nm to create complex integrated circuits. Process steps for modules in Front-end, Middle and Back-end of line are discovered and developed using the most advanced tool capabilities and they are evaluated morphologically and electrically using a relaxed test vehicle. During the development, specific challenges in metrology are assessed and metrology tools are upgraded or newly developed. The results are demonstrated in the imec pilot line with qualified metrology tools at the 5 nm node. The TAKEMI5 project relates to the ECSEL work program topic Process technologies – More Moore. It addresses and targets, as set out in the MASP, at a (disruptive) new Semiconductor Process, Equipment and Materials solutions for advanced CMOS processes that enable the module integration of electronic devices for the 5nm node in high-volume manufacturing and fast prototyping. The project touches the core of the continuation of Moore’s law which has celebrated its 50th anniversary. The cost aware development process supports the involved companies, and places them in an enhanced position for their worldwide competition. Through their worldwide affiliations, the impact of the TAKEMI5 project will be felt outside Europe in America and Asia Pacific semiconductor centers and is expected to benefit the European economy a lot by supporting its semiconductor equipment and metrology sectors with innovations, exports and employment.

The steady increase in life expectancy, mean age and cancer survivorship across the developed countries together with evidence from cancer and geriatrics care research bring forward the urgent need to deal with the “age issue” as a key component of global cancer care strategies. In 2012, an estimated 6.7 million new cases of cancer were diagnosed in adults aged 65 years and older, representing 47.5% of the total number of new cancer cases worldwide while 8% of the world population in that time was aged 65 years and older. On the other side, increasing age and comorbidities are often associated with a discriminant lower use of aggressive cancer therapies, as well as a higher neglection for their preferences in health‐related quality of life (HRQOL) care support. To address the above, LifeChamps delivers a novel, context-aware and large-scale analytics framework capable of delivering multi-dimensional Quality of Life (QOL) support to all the different cancer life champions during and after their treatments. LifeChamps is providing support to middle aged and older (pre-frail and frail) cancer patients, as well as their caregivers and healthcare professionals, with an integrated Big Data-driven solution capable to improve their QOL via a timely and more accurate clinical decision support at the point of care. Its Artificial Intelligence (AI) and analytics engine, running both at the cloud and at the mobile edge, can determine accurately which factors affect the oncological patients’ QOL the most, during and after their treatment. Furthermore, complemented by a health recommender system LifeChamps offers personalized healthcare services (i.e., symptom monitoring, treatment and rehabilitation) to these patients and their caregivers. The LifeChamps platform will be validated in four multi-national pilot use case scenarios aimed at demonstrating its applicability and validity for all the requirements of the SC1-DTH01-2019 Call (prediction, care, advice).